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Objective: We analyzed the magnitude of the association between cardiovascular disease (CVD) risk 
factors and various measures of overweight among adolescents, to determine which indicator of 
overweight is most relevant for risk assessment.  
Methods: 5,546 boys and girls aged 11–17 years participating in the German Health Interview and 
Examination Survey for Children and Adolescents (KiGGS) were studied. Overweight was assumed 
when different anthropometric variables exceeded age- and sex-specific 90th percentiles. Blood 
pressure was measured and blood samples were analyzed for serum total cholesterol, lipoproteins, 
high-sensitivity C-reactive protein, and glycosylated hemoglobin (HbA1c).  
Results: In both sexes, overweight was significantly associated with adverse levels of CVD risk 
factors, except HbA1c. These associations were most pronounced for overweight as defined by waist 
circumference (WC), waist-to-height ratio (WHtR), or BMI. Between 11% and 37% of the overweight 
children exceeded the defined cut-offs for individual CVD risk factors, with age- and puberty-adjusted 
significant odds ratios (95% confidence interval (CI)) in comparison to normal-weight age mates 
ranging from 1.7 (1.0–3.0) to 6.1 (4.5–8.2).  
Conclusions: The findings of this population-based survey suggest that, among adolescents, WC, 






Clinical and epidemiological studies among children and adolescents have consistently shown that 
overweight and obesity are associated with major biological cardiovascular disease (CVD) risk factors, 
such as insulin resistance, high blood pressure, and dyslipidemia [1–9]. In a US national sample of 
nondiabetic children examined in the third National Health and Nutrition Examination Survey 
(NHANES III), the BMI was positively related to glycosylated hemoglobin (HbA1c) [10]. Several 
analyses from the NHANES III also demonstrate that moderately elevated concentrations of C-reactive 
protein (CRP) correlate with obesity and the metabolic syndrome among children and adolescents 
[11–13]. Overweight in childhood has also been associated with vascular changes [14], higher blood 
pressure and poorer lipid risk profile [15], and cardiovascular mortality [16] in later life.  
 
Nevertheless, the relationship between childhood obesity and cardiovascular risk leaves many 
questions unanswered. Among adults, BMI and measures of central adiposity appear to be predictive 
of adverse health outcomes [17]. However, there is an ongoing debate whether childhood obesity as 
defined by BMI is an independent predictor of adult CVD risk, or whether the association is largely 
confounded by the tracking of BMI from childhood to adulthood [14, 18]. During growth and 
development, BMI may be a less appropriate measure of obesity than indices more closely related to 
body fat mass, such as skinfold thickness (SFT) and waist-to-height ratio (WHtR). Only recently, 
several studies have addressed this question, with large variations in sample size, study variables and 
methods [1, 3, 4, 6, 8]. Using the nationally representative German Health Interview and Examination 
Survey for Children and Adolescents (KiGGS), we systematically compared the relationship between 
CVD risk factors and various indicators of overweight. We asked: (1) Is there a consistent association 
between overweight measures and various CVD risk factors? (2) Which measure of overweight shows 
the strongest association with CVD risk factors and may therefore be preferably used for risk 
assessment and prevention? 
 
 
Participants and Methods 
 
Study Population 
The KiGGS study was conducted from May 2003 to May 2006. Design and sampling methods are 
described in detail elsewhere [19]. In brief, a two-stage clustered and stratified sampling procedure 
was applied. 167 sample points representative for German communities were selected in proportion to 
community size and federal state. Within these points, age- and sex-stratified random samples were 
drawn from local population registries. The response rate was 69% for 11- to 13-year-olds and 63% for 
14- to 17-year-olds. The survey was approved by the Federal Office for Data Protection and by the 
Charité University Medicine (Berlin) ethics committee. Written informed consent was obtained from all 
parents or caregivers as well as from participants themselves, if they were 14 years of age or older.  
 
For the present analysis, we excluded participants with chronic health problems or on current 
medication likely to affect one or more of the CVD risk factors under study. These included participants 
with a history of type 1 diabetes mellitus (n = 12) or hypertension (n = 21), participants on lipid-
lowering drugs (n = 8), antidiabetic medication (n = 8), glucocorticosteroids (n = 8) or 
antihypertensives (n = 17), and girls using oral contraceptives (n = 428). We further excluded 
participants with serum CRP concentrations of 10 mg/l and higher (n = 109) as this is likely to reflect 
acute inflammatory processes, and participants for whom anthropometric (n = 152) or laboratory 
variables (n = 503) were incomplete. Overall, out of 6,813 11- to 17-year-old KiGGS participants, 
1,193 (461 boys, 806 girls) were excluded. Thus, our analyses are based on data of the net study 




Participants underwent a computer-assisted medical interview and a physical examination conducted 
by trained medical staff in four study teams. Non-fasting blood samples were collected. Measurements 
of body height, body weight, triceps and subscapular SFT, waist circumference (WC) and hip 
circumference (HC) were obtained according to a highly standardized protocol. Body height was 
measured to the nearest 0.1 cm, using a portable Harpenden stadiometer (Holtain Ltd., Crymych, UK). 
Body weight was measured to the nearest 0.1 kg with a calibrated electronic scale (SECA, 
Birmingham, UK). WC was measured with a flexible non-elastic tape at the smallest abdominal 
position between the lower rib margin and the iliac crest. HC measurements were taken at the point 
yielding the maximum circumference over the buttocks. A Harpenden caliper was used to measure 
one set of triceps and subscapular SFTs on the right body side with an accuracy of 0.2 mm. 2 
readings of systolic and diastolic blood pressure (SBP, DBP) were obtained using an automated 
oscillometric device at an interval of 2 min. The arithmetic mean of the 2 measured values was used 
for the analysis.  
 
To assess the pubertal stage, participants were asked to categorize their pubic hair status according 
to Tanner stages 1–6 [20]. Pubertal stage was used as a confounder variable in the analysis and was 





Serum was separated and analyzed according to a highly standardized protocol [19]. Total cholesterol 
(TC) was analyzed using an enzymatic assay (cholesterol oxidase-PAP method) (Roche, Mannheim, 
Germany). Low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-
C) were measured directly with a homogeneous enzymatic colorimetric assay (Roche). High-sensitivity 
C-reactive protein (hs-CRP) was measured by an immunoturbidimetric assay. The initially applied 
assay (Scil Diagnostics, Martinsried, Germany) was withdrawn from the market in 2004 and was 
replaced by an equivalent assay from a different provider (Roche, Mannheim, Germany). A correction 
factor calculated with a Passing Bablok regression equation was used for the analysis. Glycosylated 
hemoglobin (HbA1c) was analyzed using high-performance liquid chromatography (HPLC; Diastat, 




Operationalization of Study Variables 
BMI was computed as the ratio of the body weight in kg and the squared body height in m². The ratio 
of WC in cm to HC in cm (WHR), the ratio of WC in cm to body height in cm (WHtR) and the sum of 2 
SFT measurements were also calculated. Overweight was defined when values exceeded the 90th 
sex- and age-specific percentile (> P90) for each of the anthropometric measures: BMI, WC, WHR, 
WHtR, and SFT measures (triceps SFT, subscapular SFT, and sum of SFT). These explanatory 
variables were treated as categorical variables throughout the analyses. In order to allow statistically 
unbiased comparisons between the various indicators of overweight, the percentiles were based on 
the net study sample so that an equal number of study subjects were characterized as overweight for 
each of the indicators. For the CVD risk factors, the 90th age- and sex-specific percentiles of the 
KiGGS study population were used to define elevated levels of SBP, DBP, and serum concentrations 
of TC, LDL-C, and HbA1c. The 10th age-and sex-specific percentile of HDL-C was chosen as a cut-off 




All analyses were stratified by sex and used sampling weights as previously described [19]. The SAS 
survey procedures (SAS version 9.2) were applied, in order to take the clustered sampling design into 
account. Descriptive statistics were computed for all continuous study variables. Means and 
corresponding 95% confidence intervals (CIs) were calculated stratified by age group and sex. 
Univariable regression models were conducted to evaluate statistically significant differences between 
boys and girls and between age groups. Means of selected CVD risk factors according to age group, 
gender, and indicator of overweight were calculated and displayed graphically. The prevalence of boys 
and girls with adverse CVD risk factor levels (> P90; except HDL-C: < P10 and hs-CRP: > 2.1 mg/l) 
was assessed according to overweight status (> P90 vs. ≤ P90) for the various overweight indicators. 
Linear regression models were calculated with individual CVD risk factors as dependent variables and 
the different indicators of overweight as main explanatory variable (> P90 vs. ≤ P90). Regression 
models were adjusted for age in years and pubertal stage as categorical variables. The coefficient of 
determination (R squared) of the regression models was used to estimate the proportion of variability 
explained by the model. Regarding SBP and DBP, we conducted a sensitivity analysis using age- and 
height-adjusted z-scores instead of the actual blood pressure readings. As results were unchanged, 





As presented in table 1, mean body height and weight as well as BMI and WC increased with age 
group in both sexes (p < 0.001). Mean WHR was lower among 14- to 17-year-olds as compared to 
younger children (p < 0.001). 14- to 17-yearold boys were taller and heavier than girls in this age 
group (p < 0.001), but the mean BMI did not statistically differ between the sexes. Among the entire 
group, the mean SFT was consistently higher for girls than for boys (p < 0.001), whereas the mean 
WC, WHR, and WHtR were higher among boys (p < 0.001). Among boys, the mean serum TC and 
lipoprotein concentrations were lower in 14- to 17-year-olds than in 11- to 13-year-olds (p < 0.001). In 
contrast, blood lipids did not differ between age groups among girls. The mean SBP and DBP values 
increased with age in both sexes (p < 0.001). At the age of 14- to 17 years, boys had significantly 
lower serum TC and lipoprotein concentrations and higher SBP and DBP than girls (p < 0.001). Mean 
hs-CRP concentrations were slightly higher among 14- to 17-year-olds than in the younger age group, 
irrespective of gender. There were no considerable differences according to age or gender in the 
mean HbA1c levels.  
 
As shown in figure 1, irrespective of the indicator chosen, boys and girls with overweight (> P90) had 
consistently higher mean SBP, LDL-C, and hs-CRP, and lower HDL-C compared to adolescents with 
normal weight (≤ P90) for each indicator of overweight. We also found higher mean levels of DBP and 
serum TC in relation to overweight status, while no mean differences in HbA1c were observed (data 
not shown).  
 
For all CVD risk factors except HbA1c, the prevalence of boys and girls exceeding the defined risk 
factor cut-off was almost 2- to 4-fold higher if they were overweight as defined by BMI, WC or WHtR, 
except for LDL-C among girls (table 2). Results from linear regression models for the various CVD risk 
factors and dichotomized measures of overweight (> P90 vs. ≤ P90), adjusted for age in years and 
pubertal stage, are shown in table 3. All cardiovascular risk factors except HbA1c were consistently 
and highly significantly related to the various measures of overweight among both sexes, independent 
of age and pubertal status. As demonstrated by the regression coefficients, overweight as defined by 
WC showed the strongest association with SBP and DBP among both sexes. Among boys, WHtR 
showed the highest association with serum TC and LDL-C as well as with hs-CRP concentrations, and 
BMI (as well as WHtR) with LDL-C. Among girls, BMI and triceps SFT showed the highest association 
with serum TC, WC with LDL-C, WHtR with HDL-C, and subscapular SFT with hs-CRP. Age- and 
puberty- adjusted differences in mean CVD risk factors between those with and without overweight 
were for example up to 9 mm Hg for SBP, 4 mm Hg for DBP, 12 mg/dl for LDL-C, –10 mg/dl for HDL-
C, and 1 mg/l for CRP. Excluding obese individuals with measures of BMI and other indices of relative 
body weight beyond the 95th age- and sex-specific percentile reduced the strength of the observed 
associations, but the associations remained statistically significant.  
 
Additionally, the percentage of body fat (calculated by using the skinfold equation of Slaughter [21]) 
was used as an overweight measure. It was shown that the percentage of body fat is not more useful 
than other overweight measures. In fact, the percentage of body fat led to results similar to those of 





In this nationally representative study of 11- to 17-year-old boys and girls in Germany, overweight as 
defined by various anthropometric measures, including BMI, WC, WHR, WHtR, and SFT, was 
significantly related to adverse levels of SBP and DBP, serum lipoproteins and serum CRP, but not to 
HbA1c. BMI, WHtR, and WC, consistently showed stronger associations with CVD risk factors than 
measures of SFT or WHR. Age- and puberty-adjusted differences in mean CVD risk factor levels 
between children and adolescents with and without overweight were substantial. The prevalence of 
girls and boys exceeding the 90th percentile cut-offs for CVD risk factors was 2–4-fold higher among 
those with and without overweight.  
 
The aim of the study was to conduct a systematic and population- based comparison of different 
anthropometric measures and to evaluate which measure of overweight shows the strongest 
association with CVD risk. For reasons of sample size considerations and to ensure statistical 
comparability, definitions of overweight according to the various anthropometric measures were 
consistently based on the 90th age- and sex-specific percentiles of the net study sample. The focus 
had to be on adolescents with percentile values within the upper margin of the distribution. For this 
purpose, using the 90th percentile as threshold is an appropriate approach [6]. Using a higher 
percentile (for example the 95th percentile) would have markedly reduced the numbers of 
observations in the upper groups and hence limited the statistical power of comparisons.  
 
In a German study of 4- to 18-year-old overweight children and adolescents referred to obesity 
centers, the degree of overweight was significantly and positively associated with SBP and DBP. In 
addition, HDL-C and overweight were weakly and negatively associated, while no association between 
overweight and TC or LDL-C was observed [7]. The latter observation disagrees with the results of the 
present study, which may at least partly be explained by methodological differences. A relationship 
between overweight and serum lipoproteins might be evident only in higher age groups and 
lipoproteins may be modulated by genetic or developmental factors [22, 23]. It has also been 
proposed that HbA1c is a good predictor of later development of type 2 diabetes mellitus in children 
[24] and has been positively related to BMI [10]. In our study, there was only a weak association 
between overweight and HbA1c among girls and none among boys. Overall, there was no large 
variation in HbA1c concentrations. The 90th age- and sex-specific percentile of HbA1c ranged 
between 5.3% and 5.4%, which does not imply elevated levels.  
 
Only few studies systematically compared different indicators of childhood obesity with respect to their 
association with CVD risk factors. In a study of Greek-Cypriot children aged 10–14 years, SBP, DBP, 
and LDL-C were significantly higher among children exceeding the 75th percentile for various 
overweight measures compared to the other children. The differences were most pronounced if WC or 
WHtR were used to define overweight [8]. In contrast, a study of 9- to 11-year-old children and 13- to 
16-year-old adolescents in Germany found that various obesity measures were similarly associated 
with blood pressure and blood lipid concentrations [6]. In agreement with our results among girls, the 
strength of the association with blood pressure was higher for WC than for BMI. In the Bogalusa Heart 
Study, WHtR showed stronger associations with lipids and lipoproteins, whereas BMI was more 
closely related to blood pressure and insulin levels [3].  
 
Our results show a weaker association between CVD risk factors and WHR and SFT, as compared to 
WC, WHtR and BMI, in particular among boys. Among adults, WHR was associated with 
cardiovascular events and diabetes mellitus [25, 26]. However, some studies have shown that WHR is 
not strongly correlated to CVD risk factors among children [27, 28]. Most likely, this is explained by the 
fact that children still undergo developmental changes of body fat distribution. Furthermore, a weaker 
association of CVD risk factors with SFT compared to weight-to-height indices has been found [2]. 
Only one set of SFT at two locations has been measured, which may not be sufficiently reliable as an 
indicator of body fat [29]. As measurements of SFT are particularly difficult to standardize due to 
observer bias and biological differences in fat distribution, misclassification may have diffused the 
association with CVD risk factors.  
 
The results of the present study are based on a large nationally representative sample of 11- to 17-
year-olds in Germany. However, there are several limitations. No fasting state blood samples were 
available, which has to be considered in the interpretation of the results. Risk factors were mainly 
analyzed as continuous variables, but an additional reflection using clinically relevant cut-offs could 
help to evaluate the public health relevance. There is, however, no evidence regarding the clinically 
relevant cut-offs for serum lipids [22, 30, 31] or blood pressure [32, 33] from long-term prospective 
studies from childhood into adulthood. Except for hs-CRP, cut-off levels for the CVD risk factors were 
defined by the age- and sex-specific 90th percentiles (10th percentile for HDL-C) observed in the 
KiGGS population. A further limitation is that we cannot exclude misclassification according to pubertal 
stage, as Tanner stages were based on self-assessment of pubic hair status. However, it may still be 
useful as a proxy for pubertal stage. Furthermore, we excluded persons who used particular 
medications that would disturb the observed associations between relative weight and CVD risk 
factors. However, analyses including all participants showed essentially similar results. In conclusion, 
the present results demonstrate that BMI, WC, and WHtR are easily applicable measures of 
overweight that appear to be relevant for CVD risk assessment among children and adolescents. We 
demonstrated a consistent association between major CVD risk factors and overweight as defined by 
various indicators in a nationally representative survey of 11- to 17-year-old German inhabitants. 
However, due to the cross-sectional design, a causal interpretation of associations is not possible. For 
(individual) risk assessment, health professionals should not only examine the weight status but 
additionally health indicators such as blood pressure and blood lipid profile. Other information like 
family history of diseases and indicators of chronic inflammation and fat distribution may also be useful 
for indirect risk assessment. The fact that an association between overweight and several CVD risk 
factors is already seen among young adolescents should be considered within the framework of 
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Tables and Figures 
 






CI = Confidence interval; hs-CRP = high-sensitivity C-reactive protein. 
 
 





P90 = Age- and sex-specific 90th percentile; P10 = age- and sex-specific 10th percentile; CI = 
confidence interval; WC = waist circumference; WHtR = waist-to-height ratio; SBP = systolic blood 
pressure; DBP = diastolic blood pressure; hs-CRP = high-sensitivity C-reactive protein; TC = total 
cholesterol; LDL-C = low-density lipoprotein cholesterol; HDL-C = high-density lipoprotein cholesterol. 
aDichotomized at the age- and sex-specific 90th percentile. Differences between ≤ P90 and > P90 
were highly significant (p < 0.001) unless explicitly mentioned (n.s. = not significant, ** = p < 0.01, * = p 













SFT = Skinfold thickness; WC = waist circumference; WHR = waist-to-hip ratio; WHtR = waist-to-
height ratio; TC = total cholesterol; LDL-C = low-density lipoprotein cholesterol; HDL-C = high-density 
lipoprotein cholesterol; SBP = systolic blood pressure; DBP = diastolic blood pressure; hs-CRP = high-
sensitivity C-reactive protein; S.E. = standard error; R2 = proportion of variance explained by the 
model. aDichotomized at the 90th age- and sex-specific percentile. bRegression coefficients (adjusted 
for age and pubertal stage) were highly significant (p < 0.001), unless stated otherwise (n.s. = not 
significant, ** = p < 0.01, * = p < 0.05). Differences between ≤ P90 and > P90 were highly significant 
































Figure 1. Means (95% CI) for CVD risk factors according to age group, gender and overweight 
dichotomized at the age- and sex-specific 90th percentile. x = overweight (> 90th percentile); ─ = 
normal weight (≤ 90th percentile); CI = confidence interval; SFT = skinfold thickness; WC = waist 
circumference; WHR = waist-to-hip ratio; WHtR = waist-to-height ratio. 
 
 
 
